medigraphic.com
SPANISH

Investigaciones Medicoquirúrgicas

ISSN 1995-9427 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 2

<< Back Next >>

Invest Medicoquir 2017; 9 (2)

Use of dipyrone–tramadol-diclofenac versus dipyrone-diclofenac in to postoperative preventive analgesic

Viña GML, Jiménez TA, Ortega BD
Full text How to cite this article

Language: Spanish
References: 0
Page: 246-260
PDF size: 80.88 Kb.


Key words:

postoperative pain (DPO), dipyrone, tramadol, diclofenac, nausea, vomiting.

ABSTRACT

Introduction. The effectiveness in the management of postoperative pain implies a multimodal and preventive approach. That is why it was important to evaluate the postoperative analgesic effectiveness of Dipyrone-Tramadol- Diclofenac versus Dipyrone-Diclofenac in lower abdominal surgeries. Methods. A descriptive, longitudinal, prospective study was conducted, including 70 patients electively scheduled for intra-abdominal surgery at the Anesthesia and Reanimation Service of Dr. Joaquín Albarrán Hospital during the period from September 2013 to September 2015. Were divided them into two comparison groups according to the mode of preventive analgesia used: Tramadol + Diclofenac / Dipyrone (n = 35) versus Diclofenac / Dipyrone (n = 35). Results. The use of Tramadol + Diclofenac / Dipirone showed a trend towards better analgesic quality compared to the Diclofenac / Dipyrone group (p = 0.072). (EVA <4 points in 68.6% vs 48.6% p = 0.124). Nausea, vomiting and epigastralgia were the main adverse effects, with a similar presentation between both modalities. Conclusions. The combination of Tramadol + Diclofenac / Dipyrone shows a trend towards better analgesic quality in the postoperative period of lower abdominal surgery, with a similar incidence of adverse effects in relation to the use of Diclofenac /Dipyrone.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Invest Medicoquir. 2017;9